Background The Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) outbreak originating in Wuhan, China, has raised global health concerns and the pandemic has now been reported on all inhabited continents. Hitherto, no antiviral drug is available to combat this viral outbreak. Methods Keeping in mind the urgency of the situation, the current study was designed to devise new strategies for drug discovery and/or repositioning against SARS-CoV-2. In the current study, RNA-dependent RNA polymerase (RdRp), which regulates viral replication, is proposed as a potential therapeutic target to inhibit viral infection. Results Evolutionary studies of whole-genome sequences of SARS-CoV-2 represent high similarity (> 90%) with other SARS viruses. Targeting the RdRp active sites, ASP760 and ASP761, by antiviral drugs could be a potential therapeutic option for inhibition of coronavirus RdRp, and thus viral replication. Target-based virtual screening and molecular docking results show that the antiviral Galidesivir and its structurally similar compounds have shown promise against SARS-CoV-2. Conclusions The anti-polymerase drugs predicted here—CID123624208 and CID11687749—may be considered for in vitro and in vivo clinical trials.
Viral diseases are a significant cause of mortality and morbidity in oysters, resulting in significant economic losses. We investigated the proteomic responses of these two species of oysters to generic double-stranded RNAs (poly I:C and poly A:U). Analysis of proteomic data using isobaric tags for relative and absolute quantitaion (iTRAQ) indicated that there were significant differences in the proteomic responses of the two oyster species resulting from this treatment. Gene ontology analysis showed that several biological processes, cellular components, and molecular function were unique to the different data sets. For example, a number of proteins implicated in the TLR signaling pathway were associated with the Saccostrea glomerata data set but were absent in the Crassostra gigas data set. These results suggest that the differences in the proteomic responses to dsRNA may underpin the biological differences in viral susceptibility. Molecular targets previously shown to be expressed in C. gigas in response to OsHV1 infections were not present in our proteomic data sets, although they were present in the RNA extracted from the very same tissues. Taken together, our data indicate that there are substantial disparities between transcriptomic and proteomic responses to dsRNA challenge, and a comprehensive account of the oysters' biological responses to these treatments must take into account that disparity.
With an increasing world population, the demand for quality food is rising. To meet safe food demand, it is necessary to double or maybe triple agriculture production. Annually, almost 25% of the world crop is destroyed due to pests. During the past few decades, different pesticides, including chemical, synthetic, biological, and botanical have been adopted to achieve adequate results against pests for agriculture interests and plant safety. Globally, more than 200,000 people died every year due to direct chemical and synthetic pesticides poisoning. But these pesticides did not achieve the desired results due to delivery problems, less stability, low biodegradability, less specificity, and high cost. To overcome these problems, the rapidly emerging field of nanotechnology is considered an important achievement in the agriculture sectors in order to improve pest mortality rates and crop production. The nano-biopesticides attained special attention against the insect pests due to their small size (1-100 nm), large surface area, high stability, cost-effectiveness, fever toxicity, and easy field application. The current chapter highlights the relevance of nano-biopesticides for pest insect management on several crops of agricultural concern. The mechanisms of action, delivery, and environmental sustainability of nano-biopesticides are also discussed in the present chapter.
In order to assess the effects of climate change and land use change on Rawal Dam, a major supply of water for Rawalpindi and Islamabad, this study uses hydrological modeling at the watershed scale. The HEC-HMS model was used to simulate the hydrological response in the Rawal Dam catchment to historical precipitation. The calibrated model was then used to determine how changes in land use and climate had an impact on reservoir inflows. The model divided the Rawal Dam watershed into six sub-basins, each with unique features, and covered the entire reservoir’s catchment area using data from three climatic stations (Murree, Islamabad Zero Point and Rawal Dam). For the time spans of 2003–2005 and 2006–2007, the model was calibrated and verified, respectively. An excellent fit between the observed and predicted flows was provided by the model. The GCM (MPI-ESM1-2-HR) produced estimates of temperature and precipitation under two Shared Socioeconomic Pathways (SSP2 and SSP5) after statistical downscaling with the CMhyd model. To evaluate potential effects of climate change and land use change on Rawal Dam, these projections, along with future circumstances for land use and land cover, were fed to the calibrated model. The analysis was carried out on a seasonal basis over the baseline period (1990–2015) and over future time horizon (2016–2100), which covers the present century. The findings point to a rise in precipitation for both SSPs, which is anticipated to result in an increase in inflows throughout the year. SSP2 projected a 15% increase in precipitation across the Rawal Dam catchment region until the end of the twenty-first century, while SSP5 forecasted a 17% increase. It was determined that higher flows are to be anticipated in the future. The calibrated model can also be utilized successfully for future hydrological impact assessments on the reservoir, it was discovered.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.